Citation Impact
Citing Papers
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
2007 StandoutScienceNobel
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
Prophylaxis in Liver Transplant Recipients Using A Fixed Dosing Schedule of Hepatitis B Immunoglobulin
1996
Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination
2004
Follicular Dendritic Cells Initiate and Maintain Infection of the Germinal Centers by Human Immunodeficiency Virus
1995
EGFR Antagonists in Cancer Treatment
2008 Standout
The Treatment of Chronic Viral Hepatitis
1997
Determinants of outcome of compensated hepatitis C virus-related cirrhosis
1998
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Are follicular dendritic cells, macrophages and interdigitating cells of the lymphoid tissue productively infected by HIV?
1994
HCV-related fibrosis progression following liver transplantation: increase in recent years
2000
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
1996 Standout
Peginterferon alfa‐2a for hepatitis C after liver transplantation
2005
Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus
2007
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C
2007
New Era of Liver Transplantation for Hepatitis B
2002
Hepatitis C Virus Infection
2001 Standout
Liver transplantation in malignant primary hepatic neoplasms
1992
Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C
2001
Rising Incidence of Hepatocellular Carcinoma in the United States
1999 Standout
Clinical aspects of hepatitis B virus infection
1993
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
1996 StandoutNobel
Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels
1998
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
2004 StandoutNobel
Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C
1998
Pegylated Interferon Alfa-2a and Ribavirin for Recurrent Hepatitis C After Liver Transplantation
2005
Viral Dynamics of Hepatitis C Early After Orthotopic Liver Transplantation: Evidence for Rapid Turnover of Serum Virions
1996
Lymphoepitelioma-like hepatocellular carcinoma: A case report and a review of the literature
2008
Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes.
1990
Hepatitis virus infections in heart transplant recipients: Epidemiology, natural history, characteristics, and impact on survival
2000
Diagnosis and treatment of autoimmune hepatitis
2002
Malnutrition as an enteric infectious disease with long-term effects on child development
2008
Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis
2006
Detection by in Situ Hybridization of HIV I RNA in Spleens of HIV I Sero-Positive Patients with Thrombocytopenic Purpura
1989
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
2004
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Viral Protein R Regulates Docking of the HIV-1 Preintegration Complex to the Nuclear Pore Complex
1998 StandoutNobel
A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation
1998
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
The circadian clock: pacemaker and tumour suppressor
2003
Outcomes After Lung Transplantation in Patients With Chronic Hepatitis C Virus Infection
2007
A 10-Year Experience of Liver Transplantation for Hepatitis C: Analysis of Factors Determining Outcome in Over 500 Patients
2001
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
1993 StandoutNature
Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C
2006
Liver Transplantation in European Patients with the Hepatitis B Surface Antigen
1993
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naïve and non-responder patients on a stable immunosuppressive regimen
2005
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
2004 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Active participation of CCR5+CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease
1999
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Hepatitis virus infections in heart transplant recipients
1995
INTERFERON-?? FOR PROPHYLAXIS OF RECURRENT VIRAL HEPATITIS C IN LIVER TRANSPLANT RECIPIENTS
1998
Liver transplantation for chronic viral hepatitis
1995
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
2004 Standout
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.
1996 StandoutNobel
A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation
2002
Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation
2005
HEPATITIS C INFECTION IN PATIENTS UNDERGOING LIVER RETRANSPLANTATION1,2
1998
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 Standout
IMPACT OF THE RECURRENCE OF HEPATITIS C VIRUS INFECTION AFTER LIVER TRANSPLANTATION ON THE LONG-TERM VIABILITY OF THE GRAFT1
2002
Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment
2001
Infection of peripheral mononuclear blood cells by hepatitis C virus
1992
Mechanisms of Exogenous Antigen Presentation by MHC Class I Molecules in Vitro and in Vivo: Implications for Generating CD8+ T Cell Responses to Infectious Agents, Tumors, Transplants, and Vaccines
1999
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
2007
Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C
2002
Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA
2001
Hepatitis C virus-specific T lymphocyte responses
1995 StandoutNobel
Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
1995 StandoutNobel
Inflammation and cancer: back to Virchow?
2001 Standout
Hepatitis C virus genotypes and quasispecies
1999
Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: Cohort study of 38 patients
2005
Hepatitis C virus genotyping by means of 5′-UR/core line probe assays and molecular analysis of untypeable samples
1995
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
TGFβ in Cancer
2008 Standout
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption
2001
Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation
2003
Complement
2001 Standout
Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes
2009 StandoutNobel
Host Circadian Clock as a Control Point in Tumor Progression
2002
Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients
1997
Complement receptors in HIV infection
1997
Recurrent hepatitis C genotype 1b following liver transplantation
2004
Treatment of Patients with Recurrent Hepatitis C after Liver Transplantation with Peginterferon Alfa-2B Plus Ribavirin
2006
Hepatitis C virus six years on
1994
NF-κB functions as a tumour promoter in inflammation-associated cancer
2004 StandoutNature
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
European collaborative study on factors influencing outcome after liver transplantation for hepatitis C
1999
Preemptive Therapy for Hepatitis C Virus after Living-Donor Liver Transplantation
2004
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
A Prospective Evaluation of Fibrosis Progression in Patients with Recurrent Hepatitis C Virus Following Liver Transplantation†
2007
Variability of the Hepatitis C Virus Genome
1998
The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation
1998
Rotating Night Shifts and Risk of Breast Cancer in Women Participating in the Nurses' Health Study
2001
Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation
2005
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
1999
Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled Study
2007
Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy
2010
Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients
1995
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation
1996
A Multicenter United States—Canadian Trial to Assess Lamivudine Monotherapy Before and After Liver Transplantation for Chronic Hepatitis B
2001
Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin
2006
Hepatitis C
1998
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Outcomes of acute rejection after interferon therapy in liver transplant recipients
2004
Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence
2003
Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus
2004 StandoutNobel
Phase II Trial of Cetuximab in Combination With Fluorouracil, Leucovorin, and Oxaliplatin in the First-Line Treatment of Metastatic Colorectal Cancer
2007
Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients.
1993
Binding of Hepatitis C Virus to CD81
1998 StandoutScienceNobel
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Primary Biliary Cirrhosis
2011 Standout
Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation
2004
Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.
1995 StandoutNobel
Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: A prospective study with hepatitis C virus RNA testing
1993
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
1996 StandoutNobel
Spermidine in health and disease
2018 StandoutScience
Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation
1994
Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer
2000
The Unenlarged Lymph Nodes of HIV-1–infected, Asymptomatic Patients with High CD4 T Cell Counts Are Sites for Virus Replication and CD4 T Cell Proliferation. The Impact of Highly Active Antiretroviral Therapy
1998 StandoutNobel
Endothelial Leukocyte Adhesion Molecule 1: an Inducible Receptor for Neutrophils Related to Complement Regulatory Proteins and Lectins
1989 StandoutScience
Mutations in the tuberous sclerosis complex geneTSC2are a cause of sporadic pulmonary lymphangioleiomyomatosis
2000
Replication of HIV-1 in Dendritic Cell-Derived Syncytia at the Mucosal Surface of the Adenoid
1996 StandoutScienceNobel
Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo
1992
Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma
2004
Phase I/II Trial of Capecitabine, Oxaliplatin, and Radiation for Rectal Cancer
2003
Critical role of reverse transcriptase in the inhibitory mechanism of CNI-H0294 on HIV-1 nuclear translocation.
1996 StandoutNobel
Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection.
1996
Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C
1993
RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase
2013 StandoutNobel
HIV replication in CD4+T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines
1996 StandoutNobel
LIVER TRANSPLANTATION FOR CHRONIC VIRAL HEPATITIS
1999
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
1998 StandoutScience
Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.
1987
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
Alterations in components of the TGF-β superfamily signaling pathways in human cancer
2005
Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis.
1994
Expression of RNA and antigens of human immunodeficiency virus type-1 (HIV-1) in lymph nodes from HIV-1 infected individuals.
1988
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication
2004 StandoutNobel
Quantitation of hepatitis C virus RNA in liver transplant recipients
1994
Works of M Reynès being referenced
Fas-mediated liver damage in MRL hemopoietic chimeras undergoing lpr-mediated graft-versus-host disease.
1997
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
1999
PERSISTENT HEPATITIS B VIRUS INFECTION OF MONONUCLEAR BLOOD CELLS WITHOUT CONCOMITANT LIVER INFECTION
1990
De novo and apparent de novo hepatitis B virus infection after liver transplantation
1997
Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation
2000
Major histocompatibility complex class I presentation of exogenously acquired minor alloantigens initiates skin allograft rejection
1997
Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients
1991
Intestinal peptide transporter PepT1 is over-expressed during acute cryptosporidiosis in suckling rats as a result of both malnutrition and experimental parasite infection
2003
Donor age influences 10-year liver graft histology independently of hepatitis C virus infection
2004
The Course of Hepatitis C Virus Infection After Liver Transplantation
1994
Preliminary results on the activity of oxaliplatin (L-OHP) in refractory/recurrent non-Hodgkin's lymphoma patients
1999
Epithelioid hemangioendothelioma of the liver
1988
The tumor promoting effect of constant light exposure on diethylnitrosamine-induced hepatocarcinogenesis in rats
1999
Reinfection of liver graft by hepatitis C virus after liver transplantation.
1992
Microsatellite instability in European hepatocellular carcinoma
1999
Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomized study
2003
All Liver Recipients Benefit From the Protocol 10–Year Liver Biopsies
2003
Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation
1995
Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease
1999
Idiopathic biliary ductopenia in adults: A report of five cases
1990
Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease
1994
Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation
1997
Granulomatous destruction of bile ducts after liver transplantation: Primary biliary cirrhosis recurrence or hepatitis C virus infection?
1995
Pulmonary lymphangioleiomyomatosis and Bourneville's tuberous sclerosis with pulmonary involvement: The same disease?
1983
Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis
1995
Lymph Node Modification in Patients with the Acquired Immunodeficiency Syndrome (AIDS) or with AIDS Related Complex (ARC)
1985
LAV-like viral particles in lymph node germinal centers in patients with the persstent lymphadenopathy syndrome and the acquired immunodeficiency syndrome-related complex: An ultrastructural study of 30 cases
1986
An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection
1995
Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.
1985